Toxicity Management and Ongoing Studies in Bispecific Antibody Treatment

This chapter provides key recommendations for physicians on managing toxicity associated with bispecific antibodies, stressing infection risk awareness and proactive measures like prophylaxis. It highlights the importance of continuous monitoring, potential dosing adjustments based on trial results, and leveraging real-world data for effective patient care.